ABSTRACT - 597648 Disclosed herein is the use of an angiotensin II receptor 1 (AT-1) antagonist for the manufacture of a pharmaceutical composition comprising a therapeutically effective amount of said angiotensin II receptor 1 (AT-1) antagonist for the treatment of systemic hypertension in cats, wherein said angiotensin II receptor (AT-1) antagonist is a sartan.